Septerna, Inc. · NASDAQ:SEPN
Long Daniel D. sold 3,333 Septerna, Inc. shares (Form 4)
Traded Jul 1, 2026 · Filed Jul 2, 2026
On Jul 1, 2026, Long Daniel D. (SVP, Drug Discovery) sold 3,333 Septerna, Inc. shares at an average US$34.36 for US$115K under a trading plan, leaving 96,412 shares. Filed Jul 2, 2026 (Form 4).
- Sold
- 3,333 shares
- Price
- US$34.36 average (US$34.10 to US$34.81)
- Value
- US$115K
- Holding after
- 96,412 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, Drug Discovery
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Option exercise | 3,333 | US$2.76 | 99,745 | Direct |
| Jul 1, 2026 | Common Stock | Sale | 2,100 | US$34.10 | 97,645 | Direct |
| Jul 1, 2026 | Common Stock | Sale | 1,233 | US$34.81 | 96,412 | Direct |
Source
Related
- Septerna, Inc.
- Long Daniel D.
- Septerna, Inc. shareholders
- Form 4 · Long Daniel D. · Sep 3, 2026
- Form 4 · Long Daniel D. · Aug 5, 2026
- Form 4 · Long Daniel D. · Jun 24, 2026
- Form 4 · Bhatt Elizabeth · Oct 19, 2026
- Form 4 · Third Rock Ventures GP VI, L.P. · Aug 14, 2026
- Form 4 · Shah Rajeev M. · Aug 14, 2026
- Schedule 13G/A · Driehaus Capital Management LLC · Aug 14, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Aug 14, 2026